A
ALXO
ALX Oncology Holdings Inc. Common Stock
$0.89
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of ALX Oncology Holdings Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$1.14
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.14
Nov 5
Posts
No posts about ALXO yet.
About ALX Oncology Holdings Inc. Common Stock
ALX Oncology is a clinical-stage biotech company that develops cancer drugs. Its lead drug aims to help the immune system attack tumor cells by blocking a signal cancers use to hide. The company has no approved product on the market and almost no revenue. It funds its research by selling shares to investors and through partnerships.